The mark consists of an image of an infinity symbol made up of various sizes of purple and orange circles appearing over the word "JOENJA" in purple font which appears over the word "LENIOLISIB" in orange font. The color white represents background and is not part of the mark.
Mark For: JOENJA LENIOLISIB™ trademark registration is intended to cover the category of
>The color(s) purple and orange is/are claimed as a feature of the mark. The mark consists of an image of an infinity symbol made up of various sizes of purple and orange circles appearing over the word "JOENJA" in purple font which appears over the word "LENIOLISIB" in orange font. The color white represents background and is not part of the mark.
Research | OneLook Acronym Finder |
Serial Number | 97343274 |
Mark Literal Elements | JOENJA LENIOLISIB |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED 2023-01-20 |
Basis | 44(e) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Mark D. Passler |
Attorney Docket Number | 12093-12 |
2022-04-01 | Application Filed |
2022-04-05 | Location: NEW APPLICATION PROCESSING |
2022-04-05 | Status: Live/Pending |
2022-04-05 | Transaction Date |
2022-08-11 | Trademark Registered |
2023-01-20 | Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED |
2023-01-20 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
Party: | Pharming Intellectual Property B.V. |
Address | Darwinweg 24 Leiden NETHERLANDS 2333CR |
Legal Entity Type | Besloten Vennootschap (b.v.) |
Legal Entity State | NETHERLANDS |
Application | 2022-04-01 | |
Drawing | 2022-04-01 | |
Design Search Code Corr Project | 2022-04-08 | |
Preliminary Amendment | 2022-09-13 | |
Amendment and Mail Process Complete | 2022-10-26 | |
Examiner's Amendment | 2023-01-20 | |
Non-Final Action | 2023-01-20 | |
summary-SearchSummary202301201444256770500507 | 2023-01-20 | |
Amendment and Mail Process Complete | 2023-01-21 |
26.01.21 | Circles that are totally or partially shaded. |
26.01.31 | Circles |
29.01.07 | Inconspicuous designs functioning as punctuation or parts of letters; Small, inconspicuous design elements functioning as punctuation or parts of letters |
241712 | Infinity symbols |
260121 | Circles that are totally or partially shaded. |
260131 | Circles |
290107 | Inconspicuous designs functioning as punctuation or parts of letters; Small, inconspicuous design elements functioning as punctuation or parts of letters |
IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of immune system related diseases and disorders
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
DM0000 | The mark consists of an image of an infinity symbol made up of various sizes of purple and orange circles appearing over the word Joenja in purple font which appears over the word leniolisib in orange font. |
DM0000 | The mark consists of an image of an infinity symbol made up of various sizes of purple and orange circles appearing over the word "JOENJA" in purple font which appears over the word "LENIOLISIB" in orange font. The color white represents background and is not part of the mark. |
Description | Date | Proceeding Number |
---|---|---|
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-01-20 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-01-20 | |
NON-FINAL ACTION WRITTEN | 2023-01-20 | 74304 |
NON-FINAL ACTION E-MAILED | 2023-01-20 | |
EXAMINERS AMENDMENT E-MAILED | 2023-01-20 | |
EXAMINERS AMENDMENT -WRITTEN | 2023-01-20 | 74304 |
EXAMINER'S AMENDMENT ENTERED | 2023-01-20 | 88888 |
ASSIGNED TO EXAMINER | 2023-01-18 | 74304 |
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2022-10-25 | 96338 |
ASSIGNED TO LIE | 2022-10-25 | 96338 |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2022-09-13 | |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2022-04-08 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-04-07 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2022-04-07 | |
NEW APPLICATION ENTERED IN TRAM | 2022-04-05 | |
NEW APPLICATION ENTERED | 2022-04-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.